.png){kind=logo}
Ypso-Facto
Description
Founded in 2014, Ypso-Facto has built strong partnerships with major pharmaceutical and biotech players, leveraging mechanistic modeling to improve bioprocess performance and sustainability. Our expertise spans a wide range of modalities and processes, including oligonucleotides, peptides, and proteins, covering both upstream and downstream processing.
At the core of our innovation is Ypso-Proxima, a unique software suite that integrates predictive simulations to streamline process development and decision-making. Combined with our tailored consulting services, we help companies scale up efficiently, optimize their bioproduction strategies, and support regulatory compliance.
By combining cutting-edge technology with deep scientific expertise, Ypso-Facto is driving the transition towards more efficient, robust, and sustainable biomanufacturing. As a proud member of France BioLead, we actively contribute to strengthening France’s leadership in bioproduction.
Find below a few examples of achievements:
- Reduction in solvent consumption by 57% in peptide solid phase synthesis
- Doubled productivity of a multi-column ion exchange chromatographic process with increased purity
- Re-established an antibiotic purification process that failed delivering the target purity following a change in raw material
- Reduced experimental work by 4 compared to DoE for an oligonucleotide ion exchange process, while getting much more knowledge
Read more about these cases on our blog !
https://www.ypsofacto.com/blog-post/